Clinical outcomes (CO) for special populations of patients (pts) with advanced non-small cell lung cancer (NSCLC): Results from ARIES, a bevacizumab (BV) observational cohort study (OCS).
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7618-7618
◽
2014 ◽
Vol 9
(9)
◽
pp. 1332-1339
◽
Keyword(s):
2016 ◽
Vol 25
(5)
◽
pp. 569-577
◽
2011 ◽
Vol 47
◽
pp. S598
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7619-7619
◽
2009 ◽
Vol 7
(2)
◽
pp. 507
◽
Keyword(s):